Nimonata, Marvin .

HRN: 27-87-96  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2025
CEFTRIAXONE 1G (VIAL)
10/02/2025
10/09/2025
IV
2g
OD
CAP-MR; Acute Cholecystitis
Waiting Final Action 
10/02/2025
AZITHROMYCIN 500MG TABLET (TAB)
10/02/2025
10/06/2025
PO
500mg
OD
CAP-MR; Acute Cholecystitis
Waiting Final Action 
10/02/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/02/2025
10/12/2025
IV
500mg
Q8h
Acute Cholecystitis
Waiting Final Action 
10/03/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/03/2025
10/16/2025
IV
4.5g
OD
CAP HR
Checking Initial Appropriateness 
10/04/2025
LEVOFLOXACIN 500MG (TAB)
10/04/2025
10/10/2025
NGT
500mg
OD
Sepsis
Waiting Final Action 
10/09/2025
LEVOFLOXACIN 500MG (TAB)
10/09/2025
10/17/2025
NGT
1 Tab
OD
Sepsis, Arf Sec To Cap Mr
Waiting Final Action 
10/10/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/10/2025
10/16/2025
IV
4.5g IV
Q6
CAP HR
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: